Suzhou, China

Hailong Yang

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Pengxu Pharmatech Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hailong Yang. Retrieved from https://idiyas.com/inventor/hailong-yang-qtx04zr8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hailong Yang - Innovator in Pharmaceutical Processes

Introduction

Hailong Yang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing important compounds.

Latest Patents

Hailong Yang holds a patent for "Processes to produce elagolix." This invention relates to a scalable process for the making of elagolix, its salts, and the process of intermediate compounds. His innovative approach has the potential to enhance the efficiency of pharmaceutical manufacturing.

Career Highlights

Yang is associated with Suzhou Pengxu Pharmatech Co., Ltd., where he applies his expertise in pharmaceutical processes. His work has been instrumental in advancing the company's capabilities in drug development.

Collaborations

Hailong Yang collaborates with talented professionals such as Pixu Li and Peng Wang. Together, they contribute to the innovative environment at Suzhou Pengxu Pharmatech Co., Ltd.

Conclusion

Hailong Yang's contributions to pharmaceutical processes exemplify the impact of innovation in the industry. His work continues to pave the way for advancements in drug manufacturing and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…